Latest News & Updates

Breaking News

  • 20 hours ago

  • Vaibhavi M.

Medicus Pharma Files EU CTIS Submission to Advance Teverelix Phase 2b Registrational Study
Breaking News
Tonix Pharmaceuticals Secures Second GPO Agreement, Expanding TONMYA Coverage to 52 Million U.S. Lives

Vaibhavi M.

Other trending news you may like to read

Medicus Pharma Files EU CTIS Submission to Advance Teverelix Phase 2b Registrational Study

Medicus Pharma files EU CTIS substantial modification to advance Teverelix Phase 2b in high cardiovascular-risk prostate cancer patients.

Vaibhavi M.

Pharma Now

Tonix Pharmaceuticals Secures Second GPO Agreement, Expanding TONMYA Coverage to 52 Million U.S. Lives

Tonix secures a second GPO agreement for TONMYA, bringing total U.S. commercial coverage to 52 million lives within 30 days of launch.

Vaibhavi M.

Pharma Now

Eledon Achieves 100% Insulin Independence Rate in Tegoprubart Islet Transplant Trial Across 12 Patients

Eledon's tegoprubart achieved 100% insulin independence in all 12 islet transplant patients, with no rejection episodes and a calcineurin inhibitor-free protocol.

Vaibhavi M.

Pharma Now

Maiva Pharma Commissions Sterile Injectables Facility in Tamil Nadu for Generic and Complex Products

Maiva Pharma commissions a sterile injectables facility in Tamil Nadu, expanding capacity for generic and complex injectable products.

Vaibhavi M.

Pharma Now